A recent study conducted on a relatively small cohort (43 enrolled patients) indicated that nebivolol may improve insulin sensitivity and glucose utilization, potentially leading to better glycemic control in patients with diabetes mellitus or cardiometabolic syndrome. Here, INS is linked to diabetes mellitus.